274
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Ventriculoperitoneal shunts in neonates: a retrospective study of outcomes with antibiotic-impregnated catheters and a modified peri-operative antibiotic protocol

, , , , &
Pages 672-676 | Received 01 Dec 2016, Accepted 12 Aug 2017, Published online: 24 Aug 2017

References

  • McAllister JP, 2nd. Pathophysiology of congenital and neonatal hydrocephalus. Semin Fetal Neonatal Med 2012;17:285–94.
  • Tully HM, Dobyns WB. Infantile hydrocephalus: a review of epidemiology, classification and causes. Eur J Med Genet 2014;57:359–68.
  • Kanev PM, Sheehan JM. Reflections on shunt infection. Pediatr Neurosurg 2003;39:285–90.
  • Vinchon M, Dhellemmes P. Cerebrospinal fluid shunt infection: risk factors and long-term follow-up. Childs Nerv Syst 2006;22:692–7.
  • Marodi L. Neonatal innate immunity to infectious agents. Infect Immun 2006;74:1999–2006.
  • Gutierrez-Gonzalez R, Boto GR. Do antibiotic-impregnated catheters prevent infection in CSF diversion procedures? Review of the literature. J Infect 2010;61:9–20.
  • Prusseit J, Simon M, von der Brelie C, et al. Epidemiology, prevention and management of ventriculoperitoneal shunt infections in children. Pediatr Neurosurg 2009;45:325–36.
  • Simon TD, Hall M, Riva-Cambrin J, et al. Hydrocephalus Clinical Research Network. Infection rates following initial cerebrospinal fluid shunt placement across pediatric hospitals in the United States. Clinical article. J Neurosurg Pediatr 2009;4:156–65.
  • Parker SL, Attenello FJ, Sciubba DM, et al. Comparison of shunt infection incidence in high-risk subgroups receiving antibiotic-impregnated versus standard shunts. Childs Nerv Syst 2009;25:77–83. discussion 85.
  • Brouwer AJ, Groenendaal F, Han KS, de Vries LS. Treatment of neonatal progressive ventricular dilatation: a single-centre experience. J Matern Fetal Neonatal Med 2015;28(Suppl 1):2273–9.
  • Bayston R, Ashraf W, Bhundia C. Mode of action of an antimicrobial biomaterial for use in hydrocephalus shunts. J Antimicrob Chemother 2004;53:778–82.
  • Kandasamy J, Dwan K, Hartley JC, et al. Antibiotic-impregnated ventriculoperitoneal shunts: a multi-centre British paediatric neurosurgery group (BPNG) study using historical controls. Childs Nerv Syst 2011;27:575–81.
  • Aryan HE, Meltzer HS, Park MS, Bennett RL, Jandial R, Levy ML. Initial experience with antibiotic-impregnated silicone catheters for shunting of cerebrospinal fluid in children. Childs Nerv Syst 2005;21:56–61.
  • James G, Hartley JC, Morgan RD, Ternier J. Effect of introduction of antibiotic-impregnated shunt catheters on cerebrospinal fluid shunt infection in children: a large single-center retrospective study. J Neurosurg Pediatr 2014;13:101–6.
  • Demetriades AK, Bassi S. Antibiotic resistant infections with antibiotic-impregnated Bactiseal catheters for ventriculoperitoneal shunts. Br J Neurosurg 2011;25:671–3.
  • Thomas R, Lee S, Patole S, Rao S. Antibiotic-impregnated catheters for the prevention of CSF shunt infections: a systematic review and meta-analysis. Br J Neurosurg 2012;26:175–84.
  • Hayhurst C, Cooke R, Williams D, Kandasamy J, O'Brien DF, Mallucci CL. The impact of antibiotic-impregnated catheters on shunt infection in children and neonates. Childs Nerv Syst 2008;24:557–62.
  • Raffa G, Marseglia L, Gitto E, Germano A. Antibiotic-impregnated catheters reduce ventriculoperitoneal shunt infection rate in high-risk newborns and infants. Childs Nerv Syst 2015;31:1129–38.
  • Klimo P, Jr., Van Poppel M, Thompson CJ, Baird LC, Duhaime AC, Flannery AM. Pediatric Hydrocephalus Systematic Review and Evidence-Based Guidelines Task Force. Pediatric hydrocephalus: systematic literature review and evidence-based guidelines. Part 6: Preoperative antibiotics for shunt surgery in children with hydrocephalus: a systematic review and meta-analysis. J Neurosurg Pediatr 2014;14(Suppl 1):44–52.
  • Ratilal B, Costa J, Sampaio C. Antibiotic prophylaxis for surgical introduction of intracranial ventricular shunts. Cochrane Database Syst Rev 2006;3:CD005365.
  • Xu H, Hu F, Hu H, et al. Antibiotic prophylaxis for shunt surgery of children: a systematic review. Childs Nerv Syst 2016;32:253–8.
  • Ratilal B, Costa J, Sampaio C. Antibiotic prophylaxis for surgical introduction of intracranial ventricular shunts: a systematic review. J Neurosurg Pediatr 2008;1:48–56.
  • von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med 2007;4:e296.
  • Eymann R, Steudel WI, Kiefer M. Infection rate with application of an antibiotic-impregnated catheter for shunt implantation in children: a retrospective analysis. Klin Padiatr 2009;221:69–73.
  • King Edward Memorial/Princess Margaret Hospitals. Insertion or Revision of Ventriculoperitoneal Shunt. NCCU Clinical Guidelines. Perth, Western Australia; 2014. Available from: http://kemh.health.wa.gov.au/services/nccu/guidelines/documents/7372.pdf [last accessed: 16 Oct 2016].
  • Fenton TR, Kim JH. A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr 2013;13:59.
  • WHO Multicentre Growth Reference Study Group. WHO Child Growth Standards: length/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: Methods and development. Geneva: World Health Organization; 2006:312.
  • Eymann R, Chehab S, Strowitzki M, Steudel WI, Kiefer M. Clinical and economic consequences of antibiotic-impregnated cerebrospinal fluid shunt catheters. J Neurosurg Pediatr 2008;1:444–50.
  • Kan P, Kestle J. Lack of efficacy of antibiotic-impregnated shunt systems in preventing shunt infections in children. Childs Nerv Syst 2007;23:773–7.
  • Pattavilakom A, Xenos C, Bradfield O, Danks RA. Reduction in shunt infection using antibiotic impregnated CSF shunt catheters: an Australian prospective study. J Clin Neurosci 2007;14:526–31.
  • Ritz R, Roser F, Morgalla M, Dietz K, Tatagiba M, Will BE. Do antibiotic-impregnated shunts in hydrocephalus therapy reduce the risk of infection? An observational study in 258 patients. BMC Infect Dis 2007;7:38.
  • Govender ST, Nathoo N, van Dellen JR. Evaluation of an antibiotic-impregnated shunt system for the treatment of hydrocephalus. J Neurosurg 2003;99:831–9.
  • Izci Y, Secer H, Akay C, Gonul E. Initial experience with silver-impregnated polyurethane ventricular catheter for shunting of cerebrospinal fluid in patients with infected hydrocephalus. Neurol Res 2009;31:234–7.
  • Jenkinson MD, Gamble C, Hartley JC, et al. The British antibiotic and silver-impregnated catheters for ventriculoperitoneal shunts multi-centre randomised controlled trial (the BASICS trial): study protocol. Trials 2014;15:4.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.